Floatz logo

Human Placental Derived Stem Cell

Severe Aplastic Anemia

New York Medical CollegeCell therapyPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

12 Active assets in the Severe Aplastic Anemia cohort.

Asset / SponsorPhaseRating
Evomela
Masonic Cancer Center, University of Minnesota
Phase 2BB
Fludarabine
Masonic Cancer Center, University of Minnesota
Phase 2BB
Cyclophosphamide
Masonic Cancer Center, University of Minnesota
Phase 2B
Fludarabine
Masonic Cancer Center, University of Minnesota
Phase 2B
Busulphan
Masonic Cancer Center, University of Minnesota
Phase 2B

View all 26 →

Same molecule, other indications

Human Placental Derived Stem Cell is also rated in:

mucopolysaccharidosis type 6Dormant
CC
Indicative ·
47 / 100
View asset →
adrenoleukodystrophyDormant
CC
Indicative ·
47 / 100
View asset →
mucopolysaccharidosis type 1Dormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →